In the pulmonary vasculature and in lung cancer, METTL3 stabilizes and promotes translation of HIF-1α, glycolytic enzymes and multiple growth factor pathways, supporting hypoxic adaptation, metabolic reprogramming and proliferative remodeling of smooth muscle cells, endothelial cells and tumor cells. This evidence concerns the gene HIF1A and lung carcinoma.